The Mechanism of Action of PTK[removed]BAY[removed]S. Weir1, A. Macone1, J. Donatelli1, C. Trieber2, D.E. Taylor2, *S.K. Tanaka1, and S.B. Levy1 Paratek Pharmaceuticals, Inc., Boston, MA1 - The University of Alberta, Edmo - Mechanism of action - Document - PDFSEARCH.IO

First Page	Meta Content
	The Mechanism of Action of PTK[removed]BAY[removed]S. Weir1, A. Macone1, J. Donatelli1, C. Trieber2, D.E. Taylor2, *S.K. Tanaka1, and S.B. Levy1 Paratek Pharmaceuticals, Inc., Boston, MA1 - The University of Alberta, Edmo Add to Reading List Document Date: 2012-10-12 16:03:21 Open Document File Size: 146,02 KB Share Result on Facebook City Edmonton / Boston / / Company S.B. Levy1 Paratek Pharmaceuticals Inc. / / / Facility S. Weir / University of Alberta / / IndustryTerm tetracycline/test competitor solutions / ribosome binding site / tetracycline binding site / / MedicalCondition S. aureus / viable S. aureus / / Organization University of Alberta / / Person Elmer Wallac / / / Product doxycycline / Ciprofloxacin / / ProvinceOrState Alberta / / Technology DNA Synthesis / / SocialTag Microbiology Bacterial diseases Staphylococcaceae Amides Otologicals Tetracycline Doxycycline Staphylococcus aureus TetR Bacteria

The Mechanism of Action of PTK[removed]BAY[removed]S. Weir1, A. Macone1, J. Donatelli1, C. Trieber2, D.E. Taylor2, *S.K. Tanaka1, and S.B. Levy1 Paratek Pharmaceuticals, Inc., Boston, MA1 - The University of Alberta, EdmoAdd to Reading List